CHMP recommends GlaxoSmithKline's Kivexa

The EU's Committee for Medicinal Products for Human Use (CHMP) recommended approval of an MAA for Kivexa abacavir/lamivudine from GlaxoSmithKline (LSE:GSK; GSK) to treat HIV in combination with other ...